Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by GOUJARD, J
Right arrow Articles by JOB, J C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GOUJARD, J
Right arrow Articles by JOB, J C
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 Oxford University Press

research-article

Human Pituitary Growth Hormone (hGH) and Creutzfeldt-Jakob Disease: Results of an Epidemiological Survey in France, 1986

J GOUJARD*, M ENTAT*, F MAILLARD*, E MUGNIER{dagger}, R RAPPAPORT{dagger} and J C JOB{ddagger}

* INSERM—Unité de Recherches Epidémiologiques sur la mère et l'enfant—123 bd de Port Royal—75014 Paris, France
{dagger} Unité d'Endocrinologie Pediatrique et Diabète. Hopital des Enfants Malades—Paris, France
{ddagger} Association France Hypophyse—Paris, France

An epidemiological inquiry has been done in France after the notification in the USA and England of four cases of Creutzfeldt-Jakob disease in patients previously treated with hGH. Between 1959, when hGH treatment in France was started, and August 1985, the date the survey began, 1698 patients were registered for treatment. Current information (less than three months old) was obtained for 1620 patients (95.4%). Death was reported in 31 patients, but none could be related to Creutzfeldt-Jakob or similar disease. Pathological events were observed in 213 living patients (13.1%). Among them, four were diseases classified as possibly related to a viral infection. The first case had acute lymphoid leukaemia; the second case had polyradiculoneuritis associated with hepatitis. In both cases the disease resolved completely. Two other patients had acute encephalitis which started less than two years after the onset of treatment and which resolved spontaneously. Even though the acute evolution and the spontaneous clinical recovery are not consistent with Creutzfeldt-Jakob disease, a relationship with hGH therapy could not be completely excluded. Finally, five treated children had later malignancies which raises the question of the long-term secondary effects of hGH upon cellular proliferation.

Revised 1 July 1987


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NeurologyHome page
A.J. Swerdlow, C.D. Higgins, P. Adlard, M.E. Jones, and M.A. Preece
Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone
Neurology, September 23, 2003; 61(6): 783 - 791.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.